IP Verse

Adaptimmune Limited opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Adaptimmune Limited

Patent Number:
EP3236985
Title:
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Hepatocellular Carcinoma (Hcc) And Other Cancers
Applicant:
IMMATICS BIOTECHNOLOGIES GMBH
Opposition Date:
Jun 25, 2020

Latest patents of Adaptimmune Limited opposed by its competitors

Patent:
EP3373013
Grant Date:
Jul 19, 2023
Title:
Method For Predicting The Off-Target Biding Of A Peptide Which Binds To A Target Peptide Presented By A Major Histocompatibility Complex
Oppositions:
3
Patent:
EP3440104
Grant Date:
Jun 14, 2023
Title:
T Cell Receptors
Oppositions:
1
Patent:
EP3060668
Grant Date:
Oct 19, 2022
Title:
Vectors For Transgene Expression
Oppositions:
1
Patent:
EP3116901
Grant Date:
Jun 12, 2019
Title:
Tcr Libraries
Oppositions:
1
Patent:
EP2936158
Grant Date:
Feb 13, 2019
Title:
Method For Predicting The Off-Target Biding Of A Peptide Which Binds To A Target Peptide Presented By A Major Histocompatibility Complex
Oppositions:
3

Competitors of Adaptimmune Limited

GRAF VON STOSCH PATENTANWALTSGESELLSCHAFT MBH

MICHALSKI HUTTERMANN & PARTNER PATENTANWALTE MBB

BISCHOF & PARTNER RECHTSANWALTE PARTNERSCHAFTSGESELLSCHAFT MBB

Want to track Adaptimmune Limited?

Feel free to send us a message here and we will get back to you